NHFOF(NHFOF)
NHFOF
No analyst ratings available
No analyst price targets available for NHFOF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $1.48T | $1.50T | $1.54T | $1.53T | $1.60T |
| Low | $1.45T | $1.42T | $1.48T | $1.47T | $1.54T |
| High | $1.51T | $1.56T | $1.58T | $1.57T | $1.64T |
| EBITDA Avg | $121.75B | $123.73B | $126.65B | $125.87B | $131.38B |
| Low | $119.07B | $117.26B | $121.93B | $121.18B | $126.49B |
| High | $123.92B | $128.08B | $130.01B | $129.21B | $134.86B |
| EBIT Avg | $77.18B | $78.44B | $80.29B | $79.79B | $83.29B |
| Low | $75.48B | $74.33B | $77.30B | $76.82B | $80.18B |
| High | $78.56B | $81.20B | $82.42B | $81.91B | $85.50B |
| Net Income Avg | $41.19B | $45.56B | $51.37B | $54.60B | $67.68B |
| Low | $39.19B | $43.35B | $48.88B | $51.96B | $64.40B |
| High | $42.61B | $47.13B | $53.14B | $56.48B | $70.01B |
| EPS Avg | $424.20 | $469.20 | $529.01 | $562.32 | $696.97 |
| Low | $403.65 | $446.47 | $503.38 | $535.08 | $663.20 |
| High | $438.81 | $485.36 | $547.24 | $581.69 | $720.98 |
| Analysts (Rev / EPS) | 7 / 1 | 8 / 1 | 4 / 1 | 4 / 1 | 3 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $380.23B | $395.29B | $346.79B |
| Low | $371.16B | $385.86B | $338.52B |
| High | $389.53B | $404.96B | $355.28B |
| EBITDA Avg | $31.29B | $32.53B | $28.54B |
| Low | $30.55B | $31.76B | $27.86B |
| High | $32.06B | $33.33B | $29.24B |
| EBIT Avg | $19.84B | $20.62B | $18.09B |
| Low | $19.37B | $20.13B | $17.66B |
| High | $20.32B | $21.13B | $18.54B |
| Net Income Avg | $10.57B | $11.72B | $2.05B |
| Low | $10.24B | $11.36B | $1.99B |
| High | $10.91B | $12.10B | $2.12B |
| EPS Avg | $127.67 | $141.62 | $24.81 |
| Low | $123.71 | $137.23 | $24.04 |
| High | $131.73 | $146.12 | $25.60 |
| Analysts (Rev / EPS) | 3 / 1 | 2 / 1 | 1 / 1 |